President's Message

-Full of LIFE-
LIFE Science and Medicine
LIFE of Hope
Quality of LIFE
Spark of LIFE

Our corporate philosophy, "Full of LIFE," derives from our efforts to realize "science and medicine that bring hope and ensure a quality way of life." Our mission is to enable patients suffering diseases and injuries to spend healthy lives that are "full of life," and this mission should be achieved through regenerative medicine that stimulates the intrinsic healing power in the living body and enables regeneration of living tissue.

Olympus Terumo Biomaterials Corp. was established based on its predecessor, Olympus Biomaterial Corp., a wholly owned subsidiary of Olympus Corp. that was established in 2004 in an attempt to advance the biomaterial business and study of regenerative medicine. Olympus Biomaterial was based on the biomaterial business of Olympus, which released the "OSferion" bone replacement material made from β-TCP (β-tricalcium phosphate) in 1999.

In 2005, the business of BONECERAM, which was made mainly from hydroxyapatite, was transferred from Sumitomo Osaka Cement Co. to Olympus Biomaterial to expand its lineup of bone replacement products.

In April 2007, Olympus Biomaterial was integrated with the collagen products business of Terumo Corp, which allowed the company to expand its scope of development of biomaterial products.
In December 2014, we began developing and selling titanium alloy implants and artificial bones exclusively for knee joint preservation treatment, which are now our core business. Joint preservation treatment aims to reduce pain and allow patients to lead an active life again without replacing their own joints with artificial ones. In order to develop this treatment, we are conducting research and development of products that are compatible with the patient's bone morphology, and are also focusing on activities such as providing educational programs and study groups to enable safe and effective surgery.

In July 2023, the collagen products business has been transferred to another company, so that we could more focus on orthopedics field, including the knee joint preservation treatment and the spine treatment in order to increase our value continuously.

We are aiming to achieve early realization of regenerative medicine that regenerates body tissue such as bone and cartilage, by combining the biomaterials such as ceramic and metal.
We will make our best efforts to deliver the "Full of Life" to people through our products by promoting research and development activities and business operations on a global scale.

President Manabu Ishikawa